Recruiting Phase II Study of Becotatug Vedotin Plus Pucotenlimab for Advanced Refractory Solid Tumors With EGFR-Positive NCT07712029 Conditions Advanced Refractory Solid Tumors, EGFR Gene Overexpression Locations Tianjin Medical Unversity Second Hospital — Tianjin, Tianjin Municipality, China View Trial Details
Recruiting Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma NCT02861898 Conditions Astrocytoma, Brain Cancer, Brain Diseases, +20 more Locations Lenox Hill Brain Tumor Center — New York, United States View Trial Details
